Leibniz Institute
The Leibniz Institute for Prevention Research and Epidemiology (BIPS) is a publicly funded non-profit research institute in Bremen, Germany, conducting population-based epidemiological research on chronic disease prevention, operating large-scale cohort and claims-data infrastructure, and serving the international scientific community, policy makers, and the WHO.
- Company typePrivate
- Founded1981
- HeadquartersBremen, Germany
- Headcount101–250
- GTM typeB2B
- OfferingServices
What Leibniz Institute does
The Leibniz-Institut für Präventionsforschung und Epidemiologie – BIPS GmbH is a non-profit research institute headquartered in Bremen, Germany, founded in 1981 and structured as a GmbH under German law. It is a full member of the Leibniz Association since January 2013 and receives institutional core funding jointly from the German federal government and the State of Bremen, supplemented by competitive grants from DFG, the European Union, and other public research funders. As of December 2025, the institute employs approximately 211 staff across departments covering epidemiological methods and cause research, clinical epidemiology, prevention and evaluation, statistical methods in epidemiology, and research data infrastructure and data science.
BIPS's core technical assets are large-scale population health research infrastructures: it serves as the Bremen examination center for the NAKO Gesundheitsstudie (Germany's largest population health study, 200,000+ participants), operates access to the GePaRD German pharmacoepidemiological research database, runs the BIPS BioBank, and hosts the Bremer Krebsregister (Bremen Cancer Registry). These feed a Research Data Portal (rdp.bips.eu) that exposes data to global researchers via metadata catalogs, the NFDI4Health Health Study Hub, and DataSHIELD-based remote analysis. The institute also develops and publishes open-source statistical software (MetS-Score, MODYS, SAS Two-Phase Package) and methodological innovations in causal inference, with code released via its GitHub organization.
Commercially, BIPS does not operate a traditional for-profit model; data, software, and consulting services are provided on a non-commercial basis to the scientific community, while policy advisory work flows to national and international bodies including the WHO (where BIPS is a designated Collaborating Centre for Obesity Prevention, Nutrition and Physical Activity since 2016). Its customer base spans the international scientific research community, healthcare policy makers, and the general population participating in cohort studies, with the institute's primary mission being the generation of scientific evidence for the prevention of chronic non-communicable diseases.
Leibniz Institute firmographics
Firmographics- Name
- Leibniz Institute
- Legal name
- Leibniz-Institut für Präventionsforschung und Epidemiologie – BIPS GmbH
- Website
- https://bips-institut.de
- Company type
- Private
- Founded year
- 1981
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Short description
- The Leibniz Institute for Prevention Research and Epidemiology (BIPS) is a publicly funded non-profit research institute in Bremen, Germany, conducting population-based epidemiological research on chronic disease prevention, operating large-scale cohort and claims-data infrastructure, and serving the international scientific community, policy makers, and the WHO.
- Ownership category
- akta.pro rank
Where Leibniz Institute is headquartered
LocationHeadquarters
- HQ city
- Bremen
- HQ country
- Germany
- HQ region
- Europe
Offices1 record
Markets served
Leibniz Institute business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Technology or R&D, Operations, Infrastructure, Marketing or Sales
Revenue model
- Government Research Funding: As a member of the Leibniz Association, BIPS receives core funding from federal and state (Bremen) governments. Additional project-based funding comes from German Research Foundation (DFG), European Union research programs, and other public research funders.
- Research Data Services: BIPS provides data access services to researchers worldwide through its Research Data Portal, enabling secondary use of epidemiological data for scientific research purposes.
Go-to-market motion2 records
Distribution channels2 records
Marketing channels5 records
Leibniz Institute product offering
Product offeringCore offering
BIPS conducts population-based epidemiological and prevention research focused on chronic non-communicable diseases, operating longitudinal cohort studies (NAKO with 200,000+ participants), pharmacoepidemiology databases (GePaRD), cancer registries (Bremer Krebsregister), and biobanking. It provides external researchers with access to its epidemiological datasets and analysis platforms via the Research Data Portal, and develops open-source statistical software for the research community.
Product overview
The Leibniz Institute for Prevention Research and Epidemiology (BIPS) is a research institution focused on population-based prevention research and epidemiology, not a traditional product company. Its offerings consist of research data infrastructure, data access platforms, and open-source statistical software tools. The core product is the Research Data Portal (https://rdp.bips.eu/), which enables external researchers to apply for and access epidemiologic data through web-based applications and remote DataSHIELD analysis. Supporting research infrastructure includes the NAKO Gesundheitsstudie (Germany's largest longitudinal health study), GePaRD (health insurance claims database), BIPS BioBank, and the Health Study Hub metadata explorer. BIPS also develops and distributes open-source software including MetS-Score for metabolic syndrome calculation, SAS Two-Phase Package for survey statistics, MODYS for adverse drug reaction monitoring, and various tools available via their GitHub repository.
Differentiator
Problem solved
Functional benefit
Products and services
- Research Data Portal Web-based portal enabling researchers worldwide to apply for and access BIPS epidemiologic research data, featuring data exploration via the Health Study Hub and remote analysis through DataSHIELD.
- NAKO Gesundheitsstudie (NAKO Health Study) Germany's largest ongoing epidemiological research project investigating causes and risk factors of common chronic diseases, with BIPS serving as the Bremen study center (200,000+ participants nationwide).
- GePaRD (German Pharmacoepidemiological Research Database) Database of German health insurance claims data enabling pharmacoepidemiological research on medication use and safety for scientific researchers.
- BIPS BioBank Bioprocessing resource supporting the conduct of epidemiological studies with biological sample collection, storage, and management.
- Bremer Krebsregister (Bremen Cancer Registry) Clinical-epidemiological cancer registry for the federal state of Bremen providing population-based cancer surveillance data.
- Research Data Infrastructure and Data Science Center Central hub bundling projects on research data infrastructure and data science, supporting FAIRification of research data and Open Science.
- Leibniz Living Lab Living lab setting in Osterholz for health-related research and community engagement in prevention research.
- MetS-Score Software tool for calculating metabolic syndrome scores used in health research.
- SAS Zwei-Phasen Paket (SAS Two-Phase Package) Statistical software package for two-phase study designs in epidemiological research.
- MODYS Statistical software for monitoring and detecting adverse drug reactions using health insurance claims data.
- BIPS GitHub Repository GitHub repository hosting open-source statistical software and tools developed at BIPS for the research community.
- DataSHIELD Remote data analysis platform enabling researchers to analyze sensitive health data without direct access, maintaining data privacy and security.
- Health Study Hub Metadata explorer developed within NFDI4Health allowing researchers to search and explore the BIPS collection of research data, study metadata, and dataset descriptions.
- IDEFICS/I.Family Dashboard Interactive dashboard providing detailed insights into the IDEFICS and I.Family cohort study data for research purposes.
Quantifiable outcome
- Leading role in Germany's largest population health study (NAKO Gesundheitsstudie)
- +1 more outcomes
Companies that use Leibniz Institute
Customer profileNamed customers3 records
Segments3 records
Ideal customer profiles2 records
Leibniz Institute technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature5 records
Leibniz Institute partnerships and signals
Strategic signalPartnerships
Eight partnerships are on record, tiered flagship, core and minor.
- World Health Organization (WHO)flagshipSince September 2016, BIPS has served as a WHO Collaborating Centre for Obesity Prevention, Nutrition and Physical Activity. The collaboration includes the Childhood Obesity Surveillance Initiative (COSI), development of training platforms for non-communicable diseases, and methodological competence platforms for surveillance harmonization across Europe.
- NAKO e.V. (NAKO Gesundheitsstudie)coreBIPS serves as the examination center for the NAKO Gesundheitsstudie, Germany's largest population-based health study with over 200,000 participants. The institute contributes to data collection, research infrastructure, and scientific analysis within this national research consortium.
- NFDI4HealthcoreBIPS participates in NFDI4Health, the National Research Data Infrastructure for personal health data. The institute contributes to the Health Study Hub and provides data collections for secondary use through this German research data initiative.
- University of BremencoreBIPS maintains close ties with the University of Bremen, where the institute operated as part of the university before becoming an independent Leibniz Institute. Collaborative research, student supervision, and academic qualification programs continue.
- European Research ConsortiacoreBIPS leads and participates in multiple European research consortia including projects on childhood nutrition (I.Family, IDEFICS), physical activity (AEQUIPA), and the Joint Programming Initiative 'A Healthy Diet for a Healthy Life'. The institute coordinates the Policy Evaluation Network (PEN).
- U Bremen Research AlliancecoreBIPS is a member of the U Bremen Research Alliance, a network of research institutions in Bremen that promotes collaboration, knowledge exchange, and joint research initiatives including the Welcome Center for international researchers.
- Leibniz AssociationcoreBIPS has been a full member of the Leibniz Association since January 2013, following associate membership since November 2008. The Leibniz Association connects over 100 non-university research institutions in Germany.
- Leibniz-WissenschaftsCampus Digital Public HealthminorBIPS leads the Leibniz-WissenschaftsCampus Digital Public Health, examining how digitalization affects health through interdisciplinary research involving IT, psychology, public health, and economics.
Scale indicators4 records
Recent moves12 records
Expansion highlights6 records
Leibniz Institute competitors and assessment
Company assessmentMarket position
Competitive moat5 records
Key highlights7 records
Customer concentration
Leibniz Institute social profiles
Digital presenceLeibniz Institute financial estimates
Financial estimateRevenue estimate
Valuation estimate
Leibniz Institute leadership team
Management profileNumber of profiles
Profiles9 records
Leibniz Institute funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Leibniz Institute M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Leibniz Institute
What does Leibniz Institute do?
BIPS conducts population-based epidemiological and prevention research focused on chronic non-communicable diseases, operating longitudinal cohort studies (NAKO with 200,000+ participants), pharmacoepidemiology databases (GePaRD), cancer registries (Bremer Krebsregister), and biobanking. It provides external researchers with access to its epidemiological datasets and analysis platforms via the Research Data Portal, and develops open-source statistical software for the research community.
Is Leibniz Institute a public or private company?
Leibniz Institute is a private company. It is classified as state government owned and is currently operating.
When was Leibniz Institute founded?
Leibniz Institute was founded in 1981. It employs 101 to 250 people.
Where is Leibniz Institute based?
Leibniz Institute is headquartered in Bremen, Germany, in the Europe region.
How does Leibniz Institute make money?
Two revenue lines are on record. Government Research Funding is the primary driver. The others are research Data Services.
Does Leibniz Institute have an API?
No public API is recorded for Leibniz Institute.